Welcome to our dedicated page for Rentokil Initial Plc SEC filings (Ticker: rklif), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Rentokil Initial Plc's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Rentokil Initial Plc's regulatory disclosures and financial reporting.
Rentokil Initial plc reported that Non-Executive Director and Person Discharging Managerial Responsibility Sally Johnson bought ordinary shares in the company. On 16 March 2026, she purchased 2,676 ordinary shares at a price of £4.828995 per share, for a total of £12,922.39.
The shares are ordinary shares of 1p each, identified by ISIN GB00B082RF11, and the transaction took place on the London Stock Exchange (XLON). The disclosure is made in line with Article 19 of the UK Market Abuse Regulation.
Rentokil Initial plc reported that Non-Executive Director and Person Discharging Managerial Responsibility Sally Johnson bought ordinary shares in the company. On 16 March 2026, she purchased 2,676 ordinary shares at a price of £4.828995 per share, for a total of £12,922.39.
The shares are ordinary shares of 1p each, identified by ISIN GB00B082RF11, and the transaction took place on the London Stock Exchange (XLON). The disclosure is made in line with Article 19 of the UK Market Abuse Regulation.
Rentokil Initial plc reported that investor BlackRock, Inc. has crossed a major shareholding threshold, with a total of 12.330000% of the company’s voting rights. This represents 312131771 voting rights in aggregate.
The position includes 9.910000% of voting rights attached to ordinary shares, representing 250562761 voting rights. A further portion is held through financial instruments, including American Depository Receipts and securities lending positions, plus contracts for difference and equity-linked notes, giving BlackRock exposure to additional voting rights in Rentokil Initial.
Rentokil Initial plc reported that investor BlackRock, Inc. has crossed a major shareholding threshold, with a total of 12.330000% of the company’s voting rights. This represents 312131771 voting rights in aggregate.
The position includes 9.910000% of voting rights attached to ordinary shares, representing 250562761 voting rights. A further portion is held through financial instruments, including American Depository Receipts and securities lending positions, plus contracts for difference and equity-linked notes, giving BlackRock exposure to additional voting rights in Rentokil Initial.
Rentokil Initial plc reported a notification of major holdings from GIC Private Limited following a change in the nature of its holding due to securities lending. GIC now holds 3.016405% of Rentokil’s voting rights through shares and 0.170558% through lent securities, giving a total of 3.186963% voting rights attached to 80,503,946 shares. This compares with a previous total interest of 3.253885%. The position includes both direct and indirect shareholdings structured through various GIC investment subsidiaries based in Singapore and the United Kingdom.
Rentokil Initial plc reported a notification of major holdings from GIC Private Limited following a change in the nature of its holding due to securities lending. GIC now holds 3.016405% of Rentokil’s voting rights through shares and 0.170558% through lent securities, giving a total of 3.186963% voting rights attached to 80,503,946 shares. This compares with a previous total interest of 3.253885%. The position includes both direct and indirect shareholdings structured through various GIC investment subsidiaries based in Singapore and the United Kingdom.
Rentokil Initial plc reports that the Samuel J. Mitchell, Jr. Revocable Trust, a person closely associated with non-executive director Samuel Mitchell, purchased 3,225 American Depositary Shares at USD 30.9598 each, for a total of USD 99,845.36, on the New York Stock Exchange on March 9 2026.
Each ADS represents five ordinary shares of one pence each in the company’s capital, so this transaction increases the trust’s indirect economic exposure to Rentokil Initial shares.
Rentokil Initial plc reports that the Samuel J. Mitchell, Jr. Revocable Trust, a person closely associated with non-executive director Samuel Mitchell, purchased 3,225 American Depositary Shares at USD 30.9598 each, for a total of USD 99,845.36, on the New York Stock Exchange on March 9 2026.
Each ADS represents five ordinary shares of one pence each in the company’s capital, so this transaction increases the trust’s indirect economic exposure to Rentokil Initial shares.
Rentokil Initial plc reported that CEO Designate Mike (Michael) Duffy, together with his Person Closely Associated, Laura Duffy, purchased 16,000 American Depositary Shares (ADSs) of the company on 9 March 2026 on the New York Stock Exchange.
The ADSs were bought at a price of USD 30.9584 per ADS, for an aggregate consideration of USD 495,334.40. Each ADS represents five ordinary shares of one pence each, and the purchase was made into a joint brokerage account held by Mike and Laura Duffy.
Rentokil Initial plc reported that CEO Designate Mike (Michael) Duffy, together with his Person Closely Associated, Laura Duffy, purchased 16,000 American Depositary Shares (ADSs) of the company on 9 March 2026 on the New York Stock Exchange.
The ADSs were bought at a price of USD 30.9584 per ADS, for an aggregate consideration of USD 495,334.40. Each ADS represents five ordinary shares of one pence each, and the purchase was made into a joint brokerage account held by Mike and Laura Duffy.
Rentokil Initial plc reported that Singapore-based investor GIC Private Limited has reduced its notifiable holding of voting rights in the company. As of 04/03/2026, GIC’s total voting interest stands at 3.253885%, representing 82,194,423 voting rights.
The position includes 2.966041% of voting rights attached to shares, split between direct and indirect holdings, and 0.287844% held via lent securities. This is a decrease from GIC’s previously notified combined interest of 3.991722%.
Rentokil Initial plc reported that Singapore-based investor GIC Private Limited has reduced its notifiable holding of voting rights in the company. As of 04/03/2026, GIC’s total voting interest stands at 3.253885%, representing 82,194,423 voting rights.
The position includes 2.966041% of voting rights attached to shares, split between direct and indirect holdings, and 0.287844% held via lent securities. This is a decrease from GIC’s previously notified combined interest of 3.991722%.
Rentokil Initial plc has begun a planned leadership transition after Chair of the Board Richard Solomons informed the Board of his intention to retire once a successor is appointed. He has served as Chair since 2019 and will continue to lead the Board until the new Chair assumes responsibilities.
The search process is underway and is being led by Senior Independent Director John Pettigrew, supported by the Nomination Committee, in line with the UK Corporate Governance Code. The company, a global provider of Pest Control and Hygiene & Wellbeing services employing about 63,400 people in 90 countries, will issue a further announcement once the new Chair is finalised.
Rentokil Initial plc has begun a planned leadership transition after Chair of the Board Richard Solomons informed the Board of his intention to retire once a successor is appointed. He has served as Chair since 2019 and will continue to lead the Board until the new Chair assumes responsibilities.
The search process is underway and is being led by Senior Independent Director John Pettigrew, supported by the Nomination Committee, in line with the UK Corporate Governance Code. The company, a global provider of Pest Control and Hygiene & Wellbeing services employing about 63,400 people in 90 countries, will issue a further announcement once the new Chair is finalised.
Rentokil Initial reported steady 2025 growth with revenue rising to $6,908m from $6,617m and Group Organic Revenue up 2.6%, helped by a stronger second half with 3.5% organic growth. Adjusted Operating Profit increased 5.4% to $1,070m, lifting the adjusted margin to 15.5%.
Free Cash Flow from continuing operations rose to $615m, up 24.5%, delivering 98% conversion and reducing net debt to $3,650m, or 2.6x Net Debt to Adjusted EBITDA. North America organic growth improved through the year, while International delivered 3.0% organic growth and a 19.8% adjusted margin.
Statutory performance was weaker, as Statutory Profit Before Tax fell to $390m from $462m, largely due to a $201m increase in the legacy termite damage provision, taking the closing balance to $384m with $95m of cash claims in 2025. The Board recommends a total 2025 dividend of 12.39 cents per share, up 3.0%, and confirms plans to reach a North America operating margin above 20% in 2027. Leadership will transition to new CEO Mike Duffy in March 2026.
Rentokil Initial reported steady 2025 growth with revenue rising to $6,908m from $6,617m and Group Organic Revenue up 2.6%, helped by a stronger second half with 3.5% organic growth. Adjusted Operating Profit increased 5.4% to $1,070m, lifting the adjusted margin to 15.5%.
Free Cash Flow from continuing operations rose to $615m, up 24.5%, delivering 98% conversion and reducing net debt to $3,650m, or 2.6x Net Debt to Adjusted EBITDA. North America organic growth improved through the year, while International delivered 3.0% organic growth and a 19.8% adjusted margin.
Statutory performance was weaker, as Statutory Profit Before Tax fell to $390m from $462m, largely due to a $201m increase in the legacy termite damage provision, taking the closing balance to $384m with $95m of cash claims in 2025. The Board recommends a total 2025 dividend of 12.39 cents per share, up 3.0%, and confirms plans to reach a North America operating margin above 20% in 2027. Leadership will transition to new CEO Mike Duffy in March 2026.
Rentokil Initial plc reports a regulatory TR-1 notification of major holdings. A shareholder now holds 2.971266% of the company’s voting rights, representing 75,055,369 voting rights attached to shares with ISIN GB00B082RF11. The table shows a previously notified position of 35% of voting rights. No voting rights are held through financial instruments, and no additional financial instruments with similar economic effect are reported.
Rentokil Initial plc reports a regulatory TR-1 notification of major holdings. A shareholder now holds 2.971266% of the company’s voting rights, representing 75,055,369 voting rights attached to shares with ISIN GB00B082RF11. The table shows a previously notified position of 35% of voting rights. No voting rights are held through financial instruments, and no additional financial instruments with similar economic effect are reported.
Rentokil Initial plc has reported a change in a director’s external roles. Chief Financial Officer Paul Edgecliffe-Johnson has been appointed as a Non-Executive Director to the Board of Watches of Switzerland Group PLC, which is listed on the London Stock Exchange, with effect from 19 February 2026.
This is an additional role for the CFO and does not alter his position at Rentokil Initial. The disclosure is made in line with applicable listing rules governing director appointments and transparency requirements.
Rentokil Initial plc has reported a change in a director’s external roles. Chief Financial Officer Paul Edgecliffe-Johnson has been appointed as a Non-Executive Director to the Board of Watches of Switzerland Group PLC, which is listed on the London Stock Exchange, with effect from 19 February 2026.
This is an additional role for the CFO and does not alter his position at Rentokil Initial. The disclosure is made in line with applicable listing rules governing director appointments and transparency requirements.